Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,398.20
(0.15%)
Lithium
41.42
(1.37%)
Iron Ore
101.4
(-2.01%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,398.20
(0.15%)
Lithium
41.42
(1.37%)
Iron Ore
101.4
(-2.01%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,398.20
(0.15%)
Lithium
41.42
(1.37%)
Iron Ore
101.4
(-2.01%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,398.20
(0.15%)
Lithium
41.42
(1.37%)
Iron Ore
101.4
(-2.01%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,398.20
(0.15%)
Lithium
41.42
(1.37%)
Iron Ore
101.4
(-2.01%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,398.20
(0.15%)
Lithium
41.42
(1.37%)
Iron Ore
101.4
(-2.01%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,398.20
(0.15%)
Lithium
41.42
(1.37%)
Iron Ore
101.4
(-2.01%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,398.20
(0.15%)
Lithium
41.42
(1.37%)
Iron Ore
101.4
(-2.01%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,398.20
(0.15%)
Lithium
41.42
(1.37%)
Iron Ore
101.4
(-2.01%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,398.20
(0.15%)
Lithium
41.42
(1.37%)
Iron Ore
101.4
(-2.01%)
Search
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,398.20
(0.15%)
Lithium
41.42
(1.37%)
Iron Ore
101.4
(-2.01%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,398.20
(0.15%)
Lithium
41.42
(1.37%)
Iron Ore
101.4
(-2.01%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,398.20
(0.15%)
Lithium
41.42
(1.37%)
Iron Ore
101.4
(-2.01%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,398.20
(0.15%)
Lithium
41.42
(1.37%)
Iron Ore
101.4
(-2.01%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,398.20
(0.15%)
Lithium
41.42
(1.37%)
Iron Ore
101.4
(-2.01%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,398.20
(0.15%)
Lithium
41.42
(1.37%)
Iron Ore
101.4
(-2.01%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,398.20
(0.15%)
Lithium
41.42
(1.37%)
Iron Ore
101.4
(-2.01%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,398.20
(0.15%)
Lithium
41.42
(1.37%)
Iron Ore
101.4
(-2.01%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,398.20
(0.15%)
Lithium
41.42
(1.37%)
Iron Ore
101.4
(-2.01%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,398.20
(0.15%)
Lithium
41.42
(1.37%)
Iron Ore
101.4
(-2.01%)

Recce Pharmaceuticals (ASX:$RCE) demonstrates efficacy against neisseria gonorrhoeae

Recce Pharmaceuticals Ltd announces positive efficacy of RECCE® 327


Recce Pharmaceuticals Ltd (ASX:$RCE) has announced positive efficacy of RECCE® 327 (R327) against Neisseria gonorrhoeae (N. gonorrhoeae) in a study conducted by Murdoch Children's Research Institute. The study demonstrated significant bactericidal activity with an approximate 4-log (99.99%) reduction in bacterial shedding after three days of treatment, and a 3.5-log (>99.9%) reduction after five days of treatment.

Executive Commentary on Efficacy Against Neisseria gonorrhoeae


James Graham, Chief Executive Officer of Recce Pharmaceuticals Ltd, emphasized the significance of the study's findings, stating, 'The need for a new class of anti-infectives could not be greater, especially against a lethal pathogen such as N. gonorrhoeae. The data from this study, along with the previous findings, emphasise the capability of R327 to demonstrate broad spectrum activity against antibiotic-resistant bacteria, even with repeated use.'

Summary of Positive Efficacy Against Neisseria gonorrhoeae


Recce Pharmaceuticals Ltd (ASX:RCE) has demonstrated positive efficacy of RECCE® 327 (R327) against Neisseria gonorrhoeae (N. gonorrhoeae) in a study conducted by Murdoch Children's Research Institute. The results showed significant bactericidal activity, with an approximate 4-log (99.99%) reduction in bacterial shedding after three days of treatment, and a 3.5-log (>99.9%) reduction after five days of treatment. The company's Chief Executive Officer, James Graham, highlighted the importance of developing new anti-infectives, especially against lethal pathogens like N. gonorrhoeae, and expressed confidence in R327's broad spectrum activity against antibiotic-resistant bacteria.

Sourcehttps://announcements.asx.com.au/asxpdf/20231214/pdf/05yk1kt9mds58p.pdf

Share to Social
0 Comments
Inline Feedbacks
View all comments

Stock Piper AI Index Coming Soon!

Join our Newsletter to gain exclusive insight and be notified once we are live.

By clicking Subscribe, you agree to our Terms & Conditions

ASX News, First And Fast.

Get all the latest market updates straight to your inbox.

By clicking Subscribe, you agree to our Terms & Conditions